Literature DB >> 30455469

Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline.

Carina L Chittim1, Ana Martínez Del Campo1, Emily P Balskus2.   

Abstract

The essential nutrient choline is metabolized by gut bacteria to the disease-associated metabolite trimethylamine (TMA). However, most of the choline obtained via the diet and present in the human body is incorporated into larger metabolites, including the lipid phosphatidylcholine (PC). Here, we report that many choline-utilizing gut microorganisms can hydrolyse PC using a phospholipase D (PLD) enzyme and further convert the released choline to TMA. Genetic and in vitro characterization of the PLD from Escherichia coli MS 200-1 showed this enzyme is essential for bacterial hydrolysis of PC and prefers this substrate. PLDs are also found in gut bacterial isolates that are unable to convert choline to TMA, suggesting that additional members of the gut microbiota may influence access to this substrate. Unexpectedly, this PLD is only distantly related to characterized PLDs from pathogenic bacteria, suggesting a distinct evolutionary history. Together, these results reveal a previously underappreciated role for gut microorganisms in phospholipid metabolism and a potential target for inhibiting TMA production.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30455469     DOI: 10.1038/s41564-018-0294-4

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  20 in total

1.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

2.  Vitamin B-12 and the Gastrointestinal Microbiome: A Systematic Review.

Authors:  Heather M Guetterman; Samantha L Huey; Rob Knight; Allison M Fox; Saurabh Mehta; Julia L Finkelstein
Journal:  Adv Nutr       Date:  2021-10-06       Impact factor: 8.701

3.  Dietary fat composition shapes bile acid metabolism and severity of liver injury in a pig model of pediatric NAFLD.

Authors:  Rodrigo Manjarín; Kayla Dillard; Morgan Coffin; Gabriella V Hernandez; Victoria A Smith; Trista Noland-Lidell; Tanvi R Gehani; Hayden J Smart; Kevin Wheeler; Kimberly A Sprayberry; Mark S Edwards; Rob K Fanter; Hunter Glanz; Chad Immoos; Tasha M Santiago-Rodriguez; Jason M Blank; Douglas G Burrin; Brian D Piccolo; Mohammed Abo-Ismail; Michael R La Frano; Magdalena Maj
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-20       Impact factor: 5.900

4.  Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.

Authors:  Tiantian Luo; Zhigang Guo; Dan Liu; Zhongzhou Guo; Qiao Wu; Qinxian Li; Rongzhan Lin; Peier Chen; Caiwen Ou; Minsheng Chen
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 5.  Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease.

Authors:  Silvia Maffei; Francesca Forini; Paola Canale; Giuseppina Nicolini; Letizia Guiducci
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 6.  The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.

Authors:  Yan Huang; Han Zhang; Xin Fan; Junpeng Wang; Yuzhen Yin; Yu Zhang; Kuangyu Shi; Fei Yu
Journal:  J Cardiovasc Transl Res       Date:  2022-10-17       Impact factor: 3.216

Review 7.  Phospholipase D and Choline Metabolism.

Authors:  Fredrick O Onono; Andrew J Morris
Journal:  Handb Exp Pharmacol       Date:  2020

Review 8.  Gut microbiota and cardiovascular disease: opportunities and challenges.

Authors:  Negin Kazemian; Morteza Mahmoudi; Frank Halperin; Joseph C Wu; Sepideh Pakpour
Journal:  Microbiome       Date:  2020-03-14       Impact factor: 14.650

9.  Microbiome and Cardiovascular Disease.

Authors:  Hilde Herrema; Max Nieuwdorp; Albert K Groen
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Comparative Metagenome-Assembled Genome Analysis of "Candidatus Lachnocurva vaginae", Formerly Known as Bacterial Vaginosis-Associated Bacterium-1 (BVAB1).

Authors:  Johanna B Holm; Michael T France; Bing Ma; Elias McComb; Courtney K Robinson; Aditya Mehta; Luke J Tallon; Rebecca M Brotman; Jacques Ravel
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.